Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical modelsReport as inadecuate




Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models - Download this document for free, or read online. Document in PDF available to download.

Journal for ImmunoTherapy of Cancer

, 2:P105

First Online: 06 November 2014DOI: 10.1186-2051-1426-2-S3-P105

Cite this article as: Huseni, M., Totpal, K., Du, C. et al. j. immunotherapy cancer 2014 2Suppl 3: P105. doi:10.1186-2051-1426-2-S3-P105 Download fulltext PDF



Author: Mahrukh Huseni - Klara Totpal - Changchun Du - Katie Dalpozzo - Jing Zhu - Deepali Rishipathak - Erin McNamara - Bernadette

Source: https://link.springer.com/



DOWNLOAD PDF




Related documents